Latest News

The AI-enabled image processing with SubtleHD(CT) software reportedly facilitates improved noise reduction and image quality for computed tomography (CT) exams.

The Reporting Pro software reportedly offers an array of AI-enabled features that may help streamline radiology reports.

In a new survey of over 2,000 health-care professionals on AI use, respondents cited benefits ranging from improved work-life balance to preventing medical errors as well as concerns about overreliance on AI and inconsistent or limited training.

In recent interviews, Emanuel Kanal, MD, and Tobias Gilk, MRSO, MRSE, noted a lack of point-of-care safety requirements for MRI, a lack of state oversight, and a prevailing lack of minimum standards overall for MRI safety.

What radiology leaders need to know about the 2026 Medicare Physician Fee Schedule.

David Gruen, MD, MBA, FACR, of Advanced Radiology Consultants, shares how leading programs turned clinical evidence into operational reality.

What's already being done with large language models in radiology practice today.

Preoperative use of (68Ga)Ga-FAPI-46 PET/CT demonstrated an 81 percent intraclass correlation coefficient (ICC) with the intraoperative peritoneal cancer index (PCI) in comparison to 76 percent for MRI and 54 percent for (18F)FDG PET/CT (FDG PET), according to new research presented at the SNMMI conference.

The proportion of breast cancer potentially flagged by three different AI algorithms 10 years prior to diagnosis ranged between 12.7 to 17 percent, according to newly published retrospective research.

Are you on the right path to financial independence and retiring early?

Catch up on a variety of new FDA clearances in radiology from the past week.

Catch up on the top radiology content of the past week.

While researchers saw no significant difference in metastasis-free survival with the use of perioperative apalutamide in patients undergoing radical prostatectomy based on conventional imaging alone, the addition of PSMA PET imaging revealed a 20 percent higher likelihood of metastasis-free survival with adjunctive apalutamide.